Regeneron-Sanofi’s drug for lung disease gets US approval
Regeneron Pharmaceuticals and Sanofi’s drug, Dupixent, got the US regulator’s approval to treat patients with chronic obstructive pulmonary disease.
Drugs
Health
Pharma
Drugs
Health
Pharma
FDA approves Cobenfy, a new treatment for schizophrenia
HQ Team 27 September, 2024: The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in
Drugs
Health
Pharma
World leaders call for action to combat antimicrobial resistance threat
HQ Team September 27, 2024: World leaders convened at the United Nations General Assembly (UNGA) on September 26, to address the escalating threat
Drugs
Health
Pharma
Indian drug body alerts public to 52 spurious medicines in market
HQ Team September 27, 2024: The Central Drugs Standard Control Organisation (CDSCO) of India recently issued a notification regarding identifying 52 spurious drugs
Drugs
Health
Medical
New research highlights alcohol use and cancer risk link
HQ Team September 26, 2024: A recent report from the American Association for Cancer Research (AACR) reveals that though cancer-related fatalities have decreased
Drugs
Health
Pharma
Evotec SE in pact with Novo Nordisk to develop cell therapy products
Evotec SE has signed a technology pact with Novo Nordisk to produce cell therapy products for clinical development and commercial use, according to
Drugs
Health
Pharma
Pfizer pulls out sickle cell therapy from global markets, cites death, snags
Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a
Drugs
Health
Pharma
Merck’s trial drug combination for colorectal cancer fails main goal
Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of
Drugs
Health
Pharma
Amgen’s trial drug to fight autoimmune disorder improves patient outcomes
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial
Drugs
Health
Pharma
IntraBio Inc.’s drug for neurogenerative disorder gets US regulator’s nod
IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain